CD4+ T cell responses improved after in vitro treatment with IL-27 and IL-7 only in subjects without signs of heart disease who have a more functional IL-27 and IL-7 axis and less exhausted immune system compared with those in patients with severe cardiomyopathy. This evidence concerns the gene IL7 and heart disorder.